Hikal Limited (HIKAL) Q2 FY27 Financial Results: PAT ₹-7 & Revenue ₹403 Cr
| Metric | Value |
|---|---|
| Revenue | ₹403 Cr |
| Net Profit (PAT) | ₹-7 |
Hikal Limited reported Q1 FY27 revenue of ₹403 crores with an EBITDA margin of 9.2%, posting a net loss of [amount context mismatch] crores due to remediation costs, though exceptional income of ₹9 crores reversed prior provisions. Capital expenditure reached ₹45 crores, debt declined to ₹685 crores, and EcoVadis recognition underscores sustainability leadership. Pharma revenue grew to ₹233 crores with 3.2% EBIT, while crop protection faced margin pressure. Management targets 15-16% FY27 revenue growth, 20%+ EBITDA margins in Animal Health, and Rs. 400 crores revenue by FY30, supported by capacity expansion and regulatory progress.
About Hikal Limited (HIKAL)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when HIKAL files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track HIKAL — Free💡 Ask AI about this filing
📊 More HIKAL filings
- 🔴 Financial Results — 6 August 2026 Hikal Limited reported consolidated revenue of ₹403 crores for Q1 FY27, up 6.2% YoY, with EBITDA mar...
- 🔴 Financial Results — 6 August 2026 Hikal Limited reported consolidated revenue of ₹403 crores for Q1 FY27, up 6.2% YoY, with EBITDA at ...
- 🟡 Board Meeting — 6 August 2026 Hikal Limited announced the outcome of its August 6, 2026 board meeting, approving unaudited standal...
- Announcement — 30 July 2026 Hikal Limited announced its Q1 FY27 earnings conference call scheduled for August 6, 2026 at 5:00 PM...
- share transfer — 9 July 2026 Hikal Limited received a confirmation certificate from MUFG Intime India Private Limited, its share ...
🔥 Also filed on 12 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when HIKAL files new disclosures
Track HIKAL filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track HIKAL — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research